Bright Minds Biosciences Inc. DRUG
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 54.28% | -270.89% | -15,429.38% | -423.06% | -2,355.60% |
| Total Depreciation and Amortization | 22.61% | -8.28% | -7.79% | -74.95% | 152.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -329.87% | -135.07% | 289.17% | 962.88% | 973.99% |
| Change in Net Operating Assets | -196.72% | 1,163.04% | -743.80% | 1,163.07% | -144.69% |
| Cash from Operations | -137.94% | -298.85% | -290.76% | -171.08% | -1,543.02% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.13% | -6.91% | -9.24% | -9.21% | -16.36% |
| Issuance of Common Stock | 1,145.45% | 97,216.84% | -71.85% | 12,069,900.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -121.40% | -- | -- |
| Cash from Financing | 592.62% | 105,981.02% | -74.16% | 139,928.90% | 23.75% |
| Foreign Exchange rate Adjustments | 928.31% | 8,968.38% | -188.43% | -3,248.36% | -2,029.76% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 56.61% | 10,513.35% | -88.19% | 6,739.28% | -1,746.71% |